Genetic Medicines Design
Protein replacement therapies, vaccines, in vivo cell reprogramming
DiscoveryActive
Key Facts
Indication
Protein replacement therapies, vaccines, in vivo cell reprogramming
Phase
Discovery
Status
Active
Company
About Lila Sciences
Lila Sciences is an ambitious AI-native biotech platform company founded in 2021, aiming to automate the entire scientific method. Its core offering, the 'AI Science Factory,' combines a proprietary AI model with autonomous laboratory hardware to accelerate R&D cycles from decades to months. While the company is private and likely pre-revenue, it has secured significant funding ($350M as of late 2025) and targets high-value discovery challenges across therapeutics, energy, materials, and more. Lila's success hinges on proving its platform's superiority over traditional research and other AI-driven approaches in generating validated, commercially viable discoveries.
View full company profile